Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-17 4:36 pm Purchase | 2025-11-13 | 13D | Cogent Biosciences, Inc. COGT | Fairmount Funds Management LLC | 15,877,418 9.900% | 1,552,500![]() (+10.84%) | Filing History |
| 2025-11-14 4:57 pm Purchase | 2025-09-30 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 10,208,060 7.200% | 3,800,000![]() (+59.30%) | Filing History |
| 2025-11-14 4:34 pm Sale | 2025-09-30 | 13G | Cogent Biosciences, Inc. COGT | Paradigm BioCapital Advisors LP | 3,156,398 2.300% | -7,196,051![]() (-69.51%) | Filing History |
| 2025-11-14 4:25 pm Purchase | 2025-09-30 | 13G | Cogent Biosciences, Inc. COGT | TCG Crossover GP I, LLC | 6,798,162 4.800% | 1,167,120![]() (+20.73%) | Filing History |
| 2025-11-14 4:16 pm Sale | 2025-09-30 | 13G | Cogent Biosciences, Inc. COGT | Point72 Asset Management, L.P. | 5,753,833 4.000% | -4,232,299![]() (-42.38%) | Filing History |
| 2025-11-14 12:36 pm Sale | 2025-09-30 | 13G | Cogent Biosciences, Inc. COGT | Kynam Capital Management, LP | 7,886,172 5.540% | -1,353,559![]() (-14.65%) | Filing History |
| 2025-08-14 6:04 pm Sale | 2025-06-30 | 13G | Cogent Biosciences, Inc. COGT | Venrock Healthcare Capital Partners II, L.P. | 4,755,411 4.200% | -1,691,506![]() (-26.24%) | Filing History |
| 2025-08-14 5:07 pm Purchase | 2025-07-07 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 6,408,060 5.500% | 1,138,836![]() (+21.61%) | Filing History |
| 2025-08-14 5:05 pm Sale | 2025-06-30 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 5,269,224 4.600% | -5,228,766![]() (-49.81%) | Filing History |
| 2025-08-14 4:31 pm Purchase | 2025-06-30 | 13G | Cogent Biosciences, Inc. COGT | Paradigm BioCapital Advisors LP | 10,352,449 9.100% | 1,388,794![]() (+15.49%) | Filing History |
| 2025-07-14 4:31 pm Purchase | 2025-07-10 | 13D | Cogent Biosciences, Inc. COGT | Fairmount Funds Management LLC | 14,324,918 9.900% | 2,994,777![]() (+26.43%) | Filing History |
| 2025-07-11 08:19 am Purchase | 2025-07-07 | 13G | Cogent Biosciences, Inc. COGT | Deerfield Mgmt, L.P. | 9,053,118 6.490% | 6,086,773![]() (+205.19%) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | Cogent Biosciences, Inc. COGT | Paradigm BioCapital Advisors LP | 8,963,655 7.900% | 3,403,731![]() (+61.22%) | Filing History |
| 2025-04-11 6:28 pm Sale | 2024-09-30 | 13G | Cogent Biosciences, Inc. COGT | Venrock Healthcare Capital Partners II, L.P. | 6,446,917 5.800% | -5,069,750![]() (-44.02%) | Filing History |
| 2025-02-14 4:10 pm Sale | 2024-12-31 | 13G | Cogent Biosciences, Inc. COGT | Point72 Asset Management, L.P. | 9,986,132 8.700% | -5,130,364![]() (-33.94%) | Filing History |
| 2025-02-12 4:35 pm Purchase | 2025-02-05 | 13G | Cogent Biosciences, Inc. COGT | Paradigm BioCapital Advisors LP | 5,559,924 5.000% | 5,559,924![]() (New Position) | Filing History |
| 2025-02-12 09:28 am Purchase | 2024-12-31 | 13G | Cogent Biosciences, Inc. COGT | FMR LLC | 16,569,256 15.000% | 3,360,284![]() (+25.44%) | Filing History |
| 2024-11-14 7:59 pm Purchase | 2024-09-30 | 13G | Cogent Biosciences, Inc. COGT | Point72 Asset Management, L.P. | 15,116,496 9.900% | 9,872,873![]() (+188.28%) | Filing History |
| 2024-11-14 5:47 pm Purchase | 2024-09-30 | 13G | Cogent Biosciences, Inc. COGT | Venrock Healthcare Capital Partners II, L.P. | 11,516,667 9.990% | 2,477,823![]() (+27.41%) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 10,497,990 9.300% | 4,325,904![]() (+70.09%) | Filing History |

